BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33621080)

  • 1. Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors.
    Yoshimura C; Nagatoishi S; Kuroda D; Kodama Y; Uno T; Kitade M; Chong-Takata K; Oshiumi H; Muraoka H; Yamashita S; Kawai Y; Ohkubo S; Tsumoto K
    J Med Chem; 2021 Mar; 64(5):2669-2677. PubMed ID: 33621080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor.
    Uno T; Kawai Y; Yamashita S; Oshiumi H; Yoshimura C; Mizutani T; Suzuki T; Chong KT; Shigeno K; Ohkubo M; Kodama Y; Muraoka H; Funabashi K; Takahashi K; Ohkubo S; Kitade M
    J Med Chem; 2019 Jan; 62(2):531-551. PubMed ID: 30525599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models.
    Ohkubo S; Kodama Y; Muraoka H; Hitotsumachi H; Yoshimura C; Kitade M; Hashimoto A; Ito K; Gomori A; Takahashi K; Shibata Y; Kanoh A; Yonekura K
    Mol Cancer Ther; 2015 Jan; 14(1):14-22. PubMed ID: 25416789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90.
    Shin SC; El-Damasy AK; Lee JH; Seo SH; Kim JH; Seo YH; Lee Y; Yu JH; Bang EK; Kim EE; Keum G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-NSCLC activity in vitro of Hsp90
    Li HJ; Wang QS; Han W; Zhou H; Li P; Zhou F; Qin W; Zhao D; Zhou X; He CX; Xing L; Li PQ; Jin X; Yu F; He JH; Cao HL
    J Struct Biol; 2021 Jun; 213(2):107710. PubMed ID: 33610655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.
    Shimomura A; Yamamoto N; Kondo S; Fujiwara Y; Suzuki S; Yanagitani N; Horiike A; Kitazono S; Ohyanagi F; Doi T; Kuboki Y; Kawazoe A; Shitara K; Ohno I; Banerji U; Sundar R; Ohkubo S; Calleja EM; Nishio M
    Mol Cancer Ther; 2019 Mar; 18(3):531-540. PubMed ID: 30679388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding conformational diversity of heat shock protein 90 (HSP90) and binding features of inhibitors to HSP90 via molecular dynamics simulations.
    Yan F; Liu X; Zhang S; Zhang Q; Chen J
    Chem Biol Drug Des; 2020 Jan; 95(1):87-103. PubMed ID: 31560152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90.
    Kazlauskas E; Petrikaitė V; Michailovienė V; Revuckienė J; Matulienė J; Grinius L; Matulis D
    PLoS One; 2012; 7(5):e36899. PubMed ID: 22655030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90).
    Mak OW; Chand R; Reynisson J; Leung IKH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex crystal structure determination and anti-non-small-cell lung cancer activity of the Hsp90
    Qin W; Yu F; Zhou H; Li P; Zhou F; Li HJ; He CX; Xing L; Zhou X; Zhao D; Li PQ; Jin X; Wang QS; He JH; Cao HL
    Acta Crystallogr D Struct Biol; 2021 Jan; 77(Pt 1):86-97. PubMed ID: 33404528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
    Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
    J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
    Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
    Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.
    Bickel D; Gohlke H
    Bioorg Med Chem; 2019 Nov; 27(21):115080. PubMed ID: 31519378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
    Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
    PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting protein-protein interactions of Hsp90 as a novel approach for targeting cancer.
    Dutta Gupta S; Bommaka MK; Banerjee A
    Eur J Med Chem; 2019 Sep; 178():48-63. PubMed ID: 31176095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP70 Is a Critical Regulator of HSP90 Inhibitor's Effectiveness in Preventing HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis.
    Colunga Biancatelli RML; Solopov PA; Day T; Gregory B; Osei-Nkansah M; Dimitropoulou C; Catravas JD
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural-thermodynamic relationships of interactions in the N-terminal ATP-binding domain of Hsp90.
    Nilapwar S; Williams E; Fu C; Prodromou C; Pearl LH; Williams MA; Ladbury JE
    J Mol Biol; 2009 Oct; 392(4):923-36. PubMed ID: 19631219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 chaperones have an energetic hot-spot for binding inhibitors.
    Hoxie RS; Street TO
    Protein Sci; 2020 Oct; 29(10):2101-2111. PubMed ID: 32812680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of 4-(1H-1,2,3-triazol-1-yl)benzamides as HSP90 inhibitors.
    He T; Zhu S; Lu W
    Mol Divers; 2023 Feb; 27(1):239-248. PubMed ID: 35429283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors.
    Neubert T; Numa M; Ernst J; Clemens J; Krenitsky P; Liu M; Fleck B; Woody L; Zuccola H; Stamos D
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1338-42. PubMed ID: 25677667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.